Work

Target validation using Phase 0 clinical trials: Promises and pitfalls

Year: 2009

Type: article

Source: Cancer Biology & Therapy

DOI: 10.4161/cbt.8.21.10154

Authors: Laura S. Angelo, Razelle Kurzrock

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Institut National de la Santé et de la Recherche Médicale, National Institutes of Health, U.S. Food and Drug Administration, National Center for Research Resources

Awards: G1826404230, Center for Clinical and Translational Sciences

OpenAlex ID: W2951172072

FWCI: 0.166

Cites:

Cited by: 1

Related to: 10